Abstract

Renal ablation (RA) is no longer used exclusively in patients with limited life expectancy. There are few studies reporting a minimum follow-up of 5 years. Biases and discrepancies within the literature are abundant. The outcomes of any series must be interpreted in the context of median follow-up time, reported tumor characteristics, ablation technique and training background of the practitioner, and the definition of tumor recurrence. The long-term oncologic efficacy of radiofrequency ablation (RFA) and cryoablation appear similar, although the percutaneous RFA technique may necessitate reablation in more cases. RA is associated with slightly higher rates of local recurrence compared to surgical excision.

Links

Publisher Full Text

Publisher Full Text

Authors

Faddegon S, Cadeddu JA

Institution

Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, J8.106, Dallas, TX 75390, USA.

Source

The Urologic clinics of North America 39:2 2012 May pg 181-90, vi

MeSH

Biopsy, Needle
Catheter Ablation
Cryosurgery
Female
Follow-Up Studies
Humans
Immunohistochemistry
Kidney Neoplasms
Male
Neoplasm Invasiveness
Neoplasm Recurrence, Local
Neoplasm Staging
Nephrectomy
Risk Assessment
Surgical Procedures, Minimally Invasive
Survival Rate
Time Factors
Treatment Outcome

Pub Type(s)

Comparative Study
Journal Article
Review

Language

eng

PubMed ID

22487761